Know Cancer

or
forgot password

Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver Enzymes


N/A
18 Years
N/A
Not Enrolling
Both
Elevated Liver Enzymes

Thank you

Trial Information

Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver Enzymes


Inclusion Criteria:



- Male or female subjects

- More than 18 years of age

- Patients with elevated liver enzymes

- Written informed consent

Exclusion Criteria:

- Patients refusing to participate to the study and to provide written informed consent

- clotting disorder

- ongoing treatment with anti-coagulant or anti-aggregant

- advanced or decompensated cirrhosis (Child-Pugh class C)

- hepatocellular carcinoma

- other cancer

- history of surgery for brain aneurysm

- pace maker or defibrillator

- ocular metal foreign body

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

liver stiffness

Outcome Time Frame:

one year

Authority:

Israel: Ministry of Health

Study ID:

0058-12-ZIV

NCT ID:

NCT01784484

Start Date:

February 2013

Completion Date:

Related Keywords:

  • Elevated Liver Enzymes
  • Fibrosis
  • Liver Cirrhosis

Name

Location